Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics

Solvent systems are integral to drug development and pharmaceutical technology. This single topic encompasses numerous allied subjects running the gamut from recrystallization solvents to biorelevant media. The goal of this contribution to the AAPS Biotechnology: Pharmaceutical Aspects series is to...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Augustijns, Patrick (Επιμελητής έκδοσης), Brewster, Marcus E. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer New York, 2007.
Σειρά:Biotechnology: Pharmaceutical Aspects ; VI
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04228nam a22004695i 4500
001 978-0-387-69154-1
003 DE-He213
005 20151204171700.0
007 cr nn 008mamaa
008 100301s2007 xxu| s |||| 0|eng d
020 |a 9780387691541  |9 978-0-387-69154-1 
024 7 |a 10.1007/978-0-387-69154-1  |2 doi 
040 |d GrThAP 
050 4 |a RM1-950 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
082 0 4 |a 615  |2 23 
245 1 0 |a Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics  |h [electronic resource] /  |c edited by Patrick Augustijns, Marcus E. Brewster. 
264 1 |a New York, NY :  |b Springer New York,  |c 2007. 
300 |a X, 462 p. 119 illus., 9 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Biotechnology: Pharmaceutical Aspects ;  |v VI 
505 0 |a Principles of Solubility -- Ionic Equilibria and the pH Dependence of Solubility -- Solvent Systems for Crystallization and Polymorph Selection -- Solubility Issues in Early Discovery and HTS -- Practical Aspects of Solubility Determination in Pharmaceutical Preformulation -- Biorelevant Dissolution Media -- Selection of Solvent Systems for Membrane-, Cell- and Tissue-Based Permeability Assessment -- The Use of Solubilizing Excipients and Approaches to Generate Toxicology Vehicles for Contemporary Drug Pipelines -- Solubilizing Vehicles for Oral Formulation Development -- Solubilizing Systems for Parenteral Formulation Development—Small Molecules -- Aqueous Solubilizing Systems for Parenteral Formulation Development—Proteins -- Non-Aqueous Systems for Formulation Development—Proteins -- Pharmaceutical Solvents as Vehicles for Topical Dosage Forms -- Pharmaceutical Solvents for Pulmonary Drug Delivery. 
520 |a Solvent systems are integral to drug development and pharmaceutical technology. This single topic encompasses numerous allied subjects running the gamut from recrystallization solvents to biorelevant media. The goal of this contribution to the AAPS Biotechnology: Pharmaceutical Aspects series is to generate both a practical handbook as well as a reference allowing the reader to make effective decisions concerning the use of solvents and solvent systems. To this end, the monograph was created by inviting recognized experts from a number of fields to author relevant sections. Specifically, 15 chapters have been designed covering the theoretical background of solubility, the effect of ionic equilibria and pH on solubilization, the use of solvents to effect drug substance crystallization and polymorph selection, the use of solvent systems in high throughput screening and early discovery, solvent use in preformulation, the use of solvents in bio-relevant dissolution and permeation experiments, solvents and their use as toxicology vehicles, solubilizing media and excipients in oral and parenteral formulation development, specialized vehicles for protein formulation and solvent systems for topical and pulmonary drug administration. The chapters are organized such that useful decision trees are included together with the scientific underpinning for their application. In addition, trends in the use of solvent systems and a balance of current views make this monograph useful to both the novice and experienced researcher and to scientists at all developmental stages from early discovery to late pharmaceutical operations. 
650 0 |a Medicine. 
650 0 |a Pharmacology. 
650 0 |a Programming languages (Electronic computers). 
650 1 4 |a Biomedicine. 
650 2 4 |a Pharmacology/Toxicology. 
650 2 4 |a Programming Languages, Compilers, Interpreters. 
700 1 |a Augustijns, Patrick.  |e editor. 
700 1 |a Brewster, Marcus E.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9780387691497 
830 0 |a Biotechnology: Pharmaceutical Aspects ;  |v VI 
856 4 0 |u http://dx.doi.org/10.1007/978-0-387-69154-1  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)